Navigation Links
Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
Date:5/7/2012

TUCSON, Ariz., May 7, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.  Currently, Ventana is the only company offering an FDA-cleared p53 image analysis algorithm for determining p53 expression levels in breast cancer patients.  Ventana is offering the p53 (DO-7) image analysis algorithm in addition to the company's FDA-cleared algorithms for HER2 (4B5), PR (1E2), and Ki-67 (30-9).

"As a market leader and long-term innovator in anatomic pathology, Ventana is committed to improving the lives of cancer patients," says Mara G. Aspinall, President, Ventana Medical Systems, Inc.  "We provide the most clinically-validated, FDA-cleared digital pathology algorithms in the market today.  When you combine this with our broad portfolio of instruments and assays, and our expertise in laboratory knowledge management and workflow, it is clear that Ventana is positioned to deliver the most comprehensive digital pathology solutions available globally."

The p53 (DO-7) image analysis algorithm assists pathologists in the detection and semi-quantitative measurement of p53 (DO-7) protein in formalin-fixed, paraffin-embedded normal and neoplastic tissue.  When the p53 (DO-7) algorithm is used in conjunction with the CONFIRM anti-p53 (DO-7) Primary Antibody, it may be used as an aid in the assessment of p53 expression in breast cancer patients (but is not the sole basis for treatment).  The FDA clearance includes all of the components of the VENTANA laboratory workflow solution when used as a system, including the company's BenchMark XT slide stainer, p53 clone DO-7, iView and ultraView DAB detection systems, VENTANA iScan Coreo Au slide scanner, and Virtuoso image manag
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ventana Introduces the BenchMark Special Stains Platform
2. Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications
3. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
4. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
5. Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Situ Hybridization Assay Systems
6. Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration
7. Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology
8. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
9. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
10. CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
11. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 A medical diagnostic technology that experts ... and on Earth was inducted recently in the Space ... assures high quality, secure handling and transmission of diagnostic ... those used in hospitals and medical offices.  Real time ... of choice for human space missions. Tests have shown ...
(Date:5/20/2013)... CARLSBAD, Calif. , May 20, 2013   ... today announced that its Applied Biosystems™ 3500 Dx and ... Federal Commission for Protection against Health Risks in ... marks a major extension of Life Technologies, capabilities to ... America with Sanger -based ...
(Date:5/20/2013)... , LONDON , BERLIN ... 20, 2013 Arthroscopy Devices ... and Preference for Minimally Invasive Procedures to Drive Future ... market trends for the six arthroscopy device market segments: ... implants, arthroscopy radio frequency systems, and arthroscopy visualization systems. ...
Breaking Medicine Technology:Wyle Aided System Gets Named to Space Technology Hall of Fame 2Wyle Aided System Gets Named to Space Technology Hall of Fame 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Nov. 11 WellTek/MedX Group, health, fitness and wellness ... corporate reorganization to facilitate becoming an SEC reporting company. ... Inc. merged into a wholly owned subsidiary of an ... subsequently changed its name to WellTek Incorporated. As ...
... (NYSE: CRY ), an implantable biological medical device ... Anderson, president and chief executive officer of CryoLife, Inc., is ... Annual Healthcare Conference on Wednesday, November 18, 2009 at 1:15 ... may be accessed through its Web site, www.cryolife.com ...
Cached Medicine Technology:WellTek/MedX Group Completes Major Reorganization 2CryoLife to Present at Upcoming Investor Conferences in New York 2
(Date:5/20/2013)... York, NY (PRWEB) May 20, 2013 ... protecting the rights of victims injured by defective drugs, ... Dakota man who alleges that use of the diabetes ... The suit was filed on April 30, 2013, in ... Louisiana (Case No. 6:13-cv-0888), where it is one of ...
(Date:5/20/2013)... May 20, 2013 According to a May ... at Indoor Tanning Salons,” tanning salons in the ... Food and Drug Administration wants to see cancer warnings on ... minimum age floor of eighteen for the use of indoor ... about melanoma, which has become increasingly common over the last ...
(Date:5/20/2013)... 2013 The Environmental Design ... dozens of continuing education credit opportunities for design ... of Architects Continuing Education System (AIA/CES), the Landscape ... Interior Design Continuing Education Council (IDCEC). EDRA44Providence ... 2013 at the Omni Providence Hotel in Providence, ...
(Date:5/20/2013)... 2013 Co-founder of Atlanta SEO ... keynote speaker at the 5th International INVEST Domaining & ... brings together company representatives and independent individuals from around ... marketing and investments. , The 2013 conference will take ... México from May 20 to 21. A networking city ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal consolidation ... lawyers to be included in a plaintiffs’ leadership committee, ... the judge’s request, noting that its lawyers can ... Mirena side effects and how to file a lawsuit. ... some female lawyers to the committee. This followed requests ...
Breaking Medicine News(10 mins):Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2
... someday help control anxiety, experts say, , , FRIDAY, May 15 ... anxiety isn,t something associated with heights, a job interview or ... state of worry and tension that affects twice as many ... slowly eroding their quality of life. , But a new ...
... ORLANDO A pill used for nerve pain offers women ... 45th Annual Meeting of the American Society of Clinical ... hot flash severity and frequency about 20 percent more than ... the same benefit as gabapentin, an older, related drug, as ...
... in GI and Endoscopy Nursing at SGNA 36th Annual ... Nurses and Associates, Inc. (SGNA) is proud to honor ... awards that recognize their dedication to the field and ... distinguished awards represent the best in GI and endoscopy ...
... Palatin Technologies, Inc. (NYSE Amex: PTN ) announced ... Palatin reported net income of $0.1 million, or $0.00 per basic ... to a net loss of $5.1 million, or $0.06 per basic ... revenues in the quarter ended March 31, 2009 were $5.2 million, ...
... 15 /PRNewswire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... distributor of high-quality, pharmaceutical grade,glucose products in China, ... of fiscal 2009 ended March 31, 2009. , ... has impacted our operations thus far in,fiscal year ...
... Dr. Bruno E. Gerber is recognized in ... is a Consultant Orthopedic Surgeon with a special ... of the lower limbs. He also is employed ... development project regarding innovative orthopedic laser treatment.Dr. Gerber ...
Cached Medicine News:Health News:Fear Response May Stem From Protein in Brain 2Health News:Mayo Clinic researchers say agent provides treatment option for women with hot flashes 2Health News:Mayo Clinic researchers say agent provides treatment option for women with hot flashes 3Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 2Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 3Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 2Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 3Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 4Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 5Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 6Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 7Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 8Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 9Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 10Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 11Health News:Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results 12Health News:Continental Who's Who Executive Press Release: Dr. Bruno E. Gerber - Medical Professional 2
... Blind Performance Specimens are intended for ... handling and transportation guidelines, including chain ... Testing Programs regulated by the Substance ... (SAMHSA), Health and Human Services Department ...
Lyphochek® Hemoglobin A1C Linearity Set is a human whole blood based product designed to verify linearity throughout the patient reportable range of hemoglobin A1C assays....
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates....
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Medicine Products: